logo

For the Inventor, By the Inventor

Corvallis, MT, United States of America

Jay Evans

This inventor holds 6 USPTO granted patents and 3 published patent applications. Top assignees: University of Montana, Children's Medical Center Corporation. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jay Evans. Retrieved from https://idiyas.com/inventor/jay-evans-nqul37o2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:

goldMedal6 out of 69 
 
University of Montana
 patents
silverMedal1 out of 1,074 
 
Children's Medical Center Corporation
 patents
where one patent can have more than one assignee

Years Active: 2022-2025

Loading Chart...
6 patents (USPTO):Explore Patents
1. 12496340 - Vaccine adjuvants based on TLR receptor ligands (2025-12-16),
2. 12319709 - Diaryl trehalose compounds and uses thereof (2025-06-03),
3. 11964014 - Vaccine adjuvants based on TLR receptor ligands (2024-04-23),
4. 11912736 - Diaryl trehalose compounds and uses thereof (2024-02-27),
5. 11572381 - Immunogenic trehalose compounds and uses thereof (2023-02-07),
6. 11464854 - Methods and compositions relating to adjuvants (2022-10-11),

Title: The Innovative Contributions of Jay Evans

Introduction

Jay Evans is a notable inventor based in Corvallis, Montana, who has made significant contributions to the field of biomedical research. With a total of five patents to his name, Evans has focused on developing compounds that have the potential to enhance vaccine efficacy and modulate immune responses.

Latest Patents

Among his latest patents, Evans has developed diaryl trehalose compounds and methods of use, particularly as vaccine adjuvants. These compounds are designed to improve the effectiveness of vaccines by enhancing the immune response. Additionally, he has patented lipidated oxoadenines that serve as TLR7/8 receptor ligands, which are useful for modulating immune responses. These innovative compounds may have therapeutic applications in treating cancer, infectious diseases, allergies, and autoimmune disorders.

Career Highlights

Throughout his career, Jay Evans has worked with esteemed institutions such as the University of Montana and Children's Medical Center Corporation. His work in these organizations has allowed him to collaborate on various research projects aimed at advancing medical science and improving patient outcomes.

Collaborations

Evans has collaborated with several notable individuals in his field, including David Burkhart and Kendal T. Ryter. These partnerships have contributed to the development of his innovative patents and have fostered a collaborative environment for research and discovery.

Conclusion

Jay Evans is a distinguished inventor

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…